Andrographolide suppresses RANKL ‐induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Guidelines for reporting experiments involving animals: the ARRIVE guidelines2010 · 1,597 citations
2. 2Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti‐inflammatory effect2002 · 357 citations
3. 3A Novel Antiinflammatory Role for Andrographolide in Asthma via Inhibition of the Nuclear Factor-κB Pathway2009 · 233 citations
4. 4NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc12007 · 409 citations
5. 512-<i>O</i>-tetradecanoylphorbol-13-acetate (TPA) Inhibits Osteoclastogenesis by Suppressing RANKL-Induced NF-κB Activation2003 · 138 citations